RESUMEN
BACKGROUND: Primary graft dysfunction (PGD) might occur after lung transplantation. In some severe cases, conventional therapies like ventilatory support, administration of inhaled nitric oxide (iNO), and intravenous prostacyclins are not sufficient to provide an adequate gas exchange. The aim of our study was to evaluate the use of a lung protective ventilation strategy associated with a low-flow venovenous CO2 removal treatment to reduce ventilator-associated injury in patients that develop severe PGD after lung transplantation. METHODS: From January 2009 to January 2011, 3 patients developed PGD within 24 hours after lung transplantation. In addition to conventional medical treatment, including hemodynamic support, iNO and prostaglandin E1 (PGE1), we initiated a ventilatory protective strategy associated with low-flow venovenous CO2 removal treatment (LFVVECCO2R). Hemodynamic and respiratory parameters were assessed at baseline as well as after 3, 12, 24, and 48 hours. RESULTS: No adverse events were registered. Despite decreased baseline elevated pulmonary positive pressures, application of a protective ventilation strategy with LFVVECCO2R reduced PaCO2 and pulmonary infiltrates as well as increased pH values and PaO2/FiO2 ratios. Every patient showed simultaneous improvement of clinical and hemodynamic conditions. They were weaned from mechanical ventilation and extubated after 24 hours after the use of the low-flow venovenous CO2 removal device. CONCLUSION: The use of LFVVECCO2R together with a protective lung ventilation strategy during the perioperative period of lung transplantation may be a valid clinical strategy for patients with PGD and severe respiratory acidosis occured despite adequate mechanical ventilation.
Asunto(s)
Acidosis/etiología , Dióxido de Carbono/aislamiento & purificación , Trasplante de Pulmón/efectos adversos , Respiración Artificial , Adulto , Dióxido de Carbono/sangre , Femenino , Humanos , Masculino , Persona de Mediana EdadRESUMEN
C3Hf/Dp mice were given a single i.p. injection of 50, 25 or 5 mug/g N-Nitroso-N-Methylurea (NMU) at either 1 or 70 days of age or 50 mug/g at 21 days of age. They were observed until death or until 120 weeks of age. The two highest doses of NMU produced tumours in a wide spectrum of organs, including the thymus, forestomach, lung, liver (only in males), kidneys, ovaries and orbital glands. The only two tumour types which appeared to be closely related to the occurrence of death were thymic lymphomata (most of which were found in mice dying before 40 weeks after treatment) and carcinomata of the forestomach. Lifetime analyses are presented concerning the occurrence of these two tumour types as well as the occurrence of any tumour after 40 weeks of age or since treatment. Incidences of thymic lymphomata were 67.6%, 39.0% and 21.2% in mice receiving 50 mug/g NMU at 1, 21 and 70 days respectively and 17.1% in mice receiving 25 mug/g at 1 day. In the other groups the incidence of thymic lymphomata was zero or negligible. The rate of progression of thymic lymphomata until death was related to both earliness of treatment and dose. On the contrary, incidences and progression of carcinomata of the forestomach were unrelated to age at treatment. Since breakdown of NMU is very rapid and does not require enzymes, these results are considered as evidence that host-tumour interaction differs from organ to organ. No excess of tumours over the controls was found in mice receiving 5 mug/g either at 1 or 70 days of age.
Asunto(s)
Factores de Edad , Metilnitrosourea/toxicidad , Neoplasias Experimentales/inducido químicamente , Compuestos de Nitrosourea/toxicidad , Animales , Animales Recién Nacidos , Relación Dosis-Respuesta a Droga , Femenino , Neoplasias Pulmonares/inducido químicamente , Linfoma/inducido químicamente , Masculino , Ratones , Ratones Endogámicos C3H , Neoplasias Experimentales/mortalidad , Neoplasias Gástricas/inducido químicamente , Neoplasias del Timo/inducido químicamenteAsunto(s)
Carcinoma Hepatocelular/inducido químicamente , DDT/toxicidad , Dimetilaminas/toxicidad , Neoplasias Hepáticas/inducido químicamente , Compuestos Nitrosos/toxicidad , Adenoma/inducido químicamente , Animales , Enfermedad Hepática Inducida por Sustancias y Drogas , Quistes/inducido químicamente , DDT/administración & dosificación , Dieta , Relación Dosis-Respuesta a Droga , Femenino , Hemangioendotelioma/inducido químicamente , Dosificación Letal Mediana , Neoplasias Hepáticas/patología , Linfoma/inducido químicamente , Masculino , Ratones , Ratones Endogámicos BALB C , Metástasis de la Neoplasia , Trasplante de Neoplasias , Factores Sexuales , Factores de Tiempo , Trasplante HomólogoAsunto(s)
Carcinógenos , Heptacloro/toxicidad , Administración Oral , Neoplasias de las Glándulas Suprarrenales/inducido químicamente , Animales , Animales Recién Nacidos , Femenino , Dosificación Letal Mediana , Masculino , Neoplasias Hipofisarias/inducido químicamente , Ratas , Neoplasias de la Tiroides/inducido químicamente , Factores de Tiempo , DesteteRESUMEN
N-Nitrosomethylurea (NMUrea) was given as a single intraperitoneal injection either to newborn or to 5-week-old (C57BL * C3Hf)F(1) mice and Wistar rats. Newborn mice were more susceptible than 5-week-old mice to the development of lymphosarcomas, lung adenomas and hepatomas, whereas newborn rats were more susceptible than their weaned counterparts to the development of renal anaplastic tumours. Other tumours occured with the same frequency in newborn and mature animals. Tumours of the forestomach in mice were more frequenty found in animals treated at 5 weeks than in those treated at birth. Since NMUrea persists for only a very short time and breaks down spontaneously it seems that the paucity of enzymes related to immaturity in newborns is not a major factor in determining the different susceptibility of newborn animals to NMUrea carcinogenicity.